Of 50 novel drugs approved by the FDA in 2021, 22 have undergone clinical trials at research sites in Poland. The attractiveness of the country and the proof of its developed landscape for ckubucak research has been getting more evident every year.
In this brochure we have outlined major information and key data on the clinical research potential in the country.
Would you like to discuss your clinical trials options in Poland? Reach out to our local team representative to learn more at poland@oct-clinicaltrials.com
